Rapid, sensitive, type specific PCR detection of the E7 region of human papillomavirus type 16 and 18 from paraffin embedded sections of cervical carcinoma

Infectious Agents and Cancer

Volumn 5, Issue 1, 2010, Pages

  Lesnikova, Iana ^a   Lidang, Marianne ^b   Hamilton Dutoit, Steven ^a   Koch, Jørn ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; PARAFFIN; PROTEIN E7;

ARTICLE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; POLYMERASE CHAIN REACTION; SIHA CELL; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; UTERINE CERVIX CARCINOMA;

EID: 77649328421     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-5-2     Document Type: Article

References (16)

1. Global cancer statistics, 2002. DM Parkin, et al. CA Cancer J Clin 2005 55 2 74 108 10.3322/canjclin.55.2.74 15761078
2. Papillomavirus infections - a major cause of human cancers. H Hausen zur, Biochim Biophys Acta 1996 1288 2 55 78 8876633
3. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. FX Bosch, et al. J Natl Cancer Inst 1995 87 11 796 802 10.1093/jnci/87.11.796 7791229
4. The human papillomavirus E6 protein and its contribution to malignant progression. F Mantovani L Banks, Oncogene 2001 20 54 7874 87 10.1038/sj.onc.1204869 11753670
5. Disruption of cell cycle control by human papillomaviruses with special reference to cervical carcinoma. SA Southern CS Herrington, Int J Gynecol Cancer 2000 10 4 263 274 10.1046/j.1525-1438.2000.010004263.x 11240685
6. How will HPV vaccines affect cervical cancer? R Roden TC Wu, Nat Rev Cancer 2006 6 10 753 763 10.1038/nrc1973 16990853
7. Touchdown General Primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus. MF Evans, et al. BMC Clin Pathol 2005 5 10 10.1186/1472-6890-5-10 16288661
8. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. W Qu, et al. J Clin Microbiol 1997 35 6 1304 10 9163434
9. Comparison of real-time PCR signal-amplified in situ hybridization and conventional PCR for detection and quantification of human papillomavirus in archival cervical cancer tissue. K Biedermann, et al. J Clin Microbiol 2004 42 8 3758 65 10.1128/JCM.42.8.3758-3765.2004 15297527
10. Feasibility of archival non-buffered formalin-fixed and paraffin-embedded tissues for PCR amplification: an analysis of resected gastric carcinoma. T Inoue, et al. Pathol Int 1996 46 12 997 1004 10.1111/j.1440-1827.1996.tb03580.x 9110353
11. Modifications of human and viral deoxyribonucleic acid by formaldehyde fixation. F Karlsen, et al. Lab Invest 1994 71 4 604 11 7967515
12. Effects of fixative and fixation time on the extraction and polymerase chain reaction amplification of RNA from paraffin-embedded tissue. Comparison of two housekeeping gene mRNA controls. RD Foss, et al. Diagn Mol Pathol 1994 3 3 148 55 10.1097/00019606-199409000-00003 7981889
13. Detection of bovine viral diarrhea virus RNA in formalin-fixed, paraffin-embedded brain tissue by nested polymerase chain reaction. AD Gruber, et al. J Virol Methods 1993 43 3 309 19 10.1016/0166-0934(93)90149-L 8408445
14. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. JD Meissner, J Gen Virol 1999 80 Pt 7 1725 33 10423141
15. Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction. TE Godfrey, et al. J Mol Diagn 2000 2 2 84 91 11272893
16. Papillomaviruses in human cancer. H zur Hausen, Appl Pathol 1987 5 1 19 24 3040050 (Pubitemid 17110738)